These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22855503)

  • 21. From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics.
    Bending D; Ono M
    Clin Exp Immunol; 2019 Jul; 197(1):14-23. PubMed ID: 30076771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacity.
    Zong X; Hao X; Xu B; Crawford JC; Wright S; Li J; Zhang Y; Bai L; He M; Jiang M; Fan Y; Connelly JP; Pruett-Miller SM; Berns H; Janke L; Li C; Feng Y
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34086055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Foxo1-dependent transcriptional programs control T(reg) cell function.
    Ouyang W; Liao W; Luo CT; Yin N; Huse M; Kim MV; Peng M; Chan P; Ma Q; Mo Y; Meijer D; Zhao K; Rudensky AY; Atwal G; Zhang MQ; Li MO
    Nature; 2012 Nov; 491(7425):554-9. PubMed ID: 23135404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation.
    Beyer M; Thabet Y; Müller RU; Sadlon T; Classen S; Lahl K; Basu S; Zhou X; Bailey-Bucktrout SL; Krebs W; Schönfeld EA; Böttcher J; Golovina T; Mayer CT; Hofmann A; Sommer D; Debey-Pascher S; Endl E; Limmer A; Hippen KL; Blazar BR; Balderas R; Quast T; Waha A; Mayer G; Famulok M; Knolle PA; Wickenhauser C; Kolanus W; Schermer B; Bluestone JA; Barry SC; Sparwasser T; Riley JL; Schultze JL
    Nat Immunol; 2011 Aug; 12(9):898-907. PubMed ID: 21841785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
    Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
    J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
    Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
    J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-β signaling controls
    Sun X; Cui Y; Feng H; Liu H; Liu X
    J Exp Med; 2019 Dec; 216(12):2819-2837. PubMed ID: 31515281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
    Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
    J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors and transplantation.
    Tao R; de Zoeten EF; Ozkaynak E; Wang L; Li B; Greene MI; Wells AD; Hancock WW
    Curr Opin Immunol; 2007 Oct; 19(5):589-95. PubMed ID: 17719760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.
    Haxhinasto S; Mathis D; Benoist C
    J Exp Med; 2008 Mar; 205(3):565-74. PubMed ID: 18283119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.
    Kuczma M; Kopij M; Pawlikowska I; Wang CY; Rempala GA; Kraj P
    PLoS One; 2010 Oct; 5(10):e13623. PubMed ID: 21049016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature.
    Hill JA; Feuerer M; Tash K; Haxhinasto S; Perez J; Melamed R; Mathis D; Benoist C
    Immunity; 2007 Nov; 27(5):786-800. PubMed ID: 18024188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS
    J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells.
    Chang JH; Xiao Y; Hu H; Jin J; Yu J; Zhou X; Wu X; Johnson HM; Akira S; Pasparakis M; Cheng X; Sun SC
    Nat Immunol; 2012 May; 13(5):481-90. PubMed ID: 22484734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway.
    Grainger JR; Smith KA; Hewitson JP; McSorley HJ; Harcus Y; Filbey KJ; Finney CA; Greenwood EJ; Knox DP; Wilson MS; Belkaid Y; Rudensky AY; Maizels RM
    J Exp Med; 2010 Oct; 207(11):2331-41. PubMed ID: 20876311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
    Shen L; Ciesielski M; Ramakrishnan S; Miles KM; Ellis L; Sotomayor P; Shrikant P; Fenstermaker R; Pili R
    PLoS One; 2012; 7(1):e30815. PubMed ID: 22303460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.
    Schmidt A; Oberle N; Weiss EM; Vobis D; Frischbutter S; Baumgrass R; Falk CS; Haag M; Brügger B; Lin H; Mayr GW; Reichardt P; Gunzer M; Suri-Payer E; Krammer PH
    Sci Signal; 2011 Dec; 4(204):ra90. PubMed ID: 22375050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the controversial role of PI3K signalling in CD4
    Poli A; Fiume R; Mongiorgi S; Zaurito A; Sheth B; Vidalle MC; Hamid SA; Kimber S; Campagnoli F; Ratti S; Rusciano I; Faenza I; Manzoli L; Divecha N
    Adv Biol Regul; 2020 May; 76():100722. PubMed ID: 32362560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.